Multi-Site Study of COVID-19 Patients Utilizing Fluidigm Mass Cytometry Technology and Maxpar Direct Immune Profiling Assay

  • Adeeb Rahman

Press/Media

Period30 Jun 2020

Media coverage

1

Media coverage